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The placenta performs a wide range of physiological functions; insufﬁciencies in these functions may
result in a variety of severe prenatal and postnatal syndromes with long-term negative impacts on
human adult health. Recent advances in magnetic resonance imaging (MRI) studies of placental function,
in both animal models and humans, have contributed signiﬁcantly to our understanding of placental
structure, blood ﬂow, oxygenation status, and metabolic proﬁle, and have provided important insights
into pregnancy complications.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Magnetic Resonance Imaging (MRI) is a versatile and powerful
modality, which reveals, non-invasively, both structural and
functional dynamic information, with high soft-tissue contrast
and high spatial resolution. Functional MRI studies are particu-
larly well-suited to the analysis of placental vascular physiology
and function, as they provide a wide range of methods for
detection of essential physiological parameters, such as blood
ﬂow, perfusion and oxygenation status. Many of these methods
are based on the indicator dilution principle, in which a small
amount of tracer introduced into the blood stream can be used for
analysis of blood volume. However, in contrast to analytical
determination of the tracer concentration in blood samples, in
MRI, the tracer is detected indirectly by relying on a small number
of fundamental contrast mechanisms, many of which will be
described herein. In particular, this review will describe experi-
ments that rely on changes in the major magnetic relaxation time
constants, T1, T2 and T2*. T1 is the time constant for relaxation of
the magnetic moment to its steady-state equilibrium condition
along the main magnetic ﬁeld of the MRI, and T2/T2* are two time
constants associated with the dispersion of the magnetization in
the plane perpendicular to the magnetic ﬁeld, and, thus, loss of a
coherent signal from the radio frequency (rf) excited nuclei (These
MRI terms and the different methodologies are explained more: þ1 314 362 0526.
: þ972 8 9346264.
(M. Neeman), garbow@wustl.
Ltd. This is an open access article ufully in the Supplementary Text). Major challenges in modern day
obstetrics include the identiﬁcation of fetuses and mothers at high
risk, diagnosis and quantiﬁcation of placental insufﬁciency, and
prediction of clinical outcome. In current clinical practice,
screening and follow-up are largely based on ultrasound (US)
assessments; however these measurements only provide an in-
direct estimate of placental function. Development of comple-
mentary, non-invasive MRI tools capable of assessing placental
function may improve diagnosis of pregnancy complications, such
as intrauterine growth restriction (IUGR) and preeclampsia (PE),
and potentially assist in decisions on the timing of delivery and on
perinatal outcome. Over the past few years, a number of MRI
methods were developed and employed to study placental func-
tion in animal studies and in the clinical settings, including
perfusion measurements using Dynamic Contrast Enhanced MRI
(DCE-MRI), in which T1 is altered by intravenous administration of
contrast agents [1e17]; perfusion measurements using arterial
spin labeling (ASL), in which the measured T1 is affected by blood
ﬂow [18e23]; oxygenation studies using blood oxygen level
dependent (BOLD), in which T2* changes reﬂect changes in he-
moglobin saturation [24e31]; and oxygen enhanced (OE) T1 [31].
Diffusion weighted MRI (DW MRI) [32e42] probes the micro-
structural properties of tissue by measuring the incoherent mo-
tion of water within the tissue. Lastly, the dependence of
resonance frequency on local chemical environment enables
Magnetic Resonance Spectroscopy (MRS) as a tool for metabolic
studies [43e46]. In this review, we will explain the basis of each of
these methods and examine their application, starting from pre-
clinical small-animal models, progressing to larger animal models
and, ﬁnally, to human studies.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Dynamic contrast-enhanced MRI (DCE-MRI) is a widely used
technique for in vivo mapping of vascular function, providing
important insight into multiple parameters including blood ﬂow,
perfusion, fractional blood volume, extracellular volume fraction
and vascular permeability. DCE-MRI experiments are based on the
observed shortening of T1 following the administration of contrast
agents, either low-molecular-weight or high-molecular-weight
(macromolecular) chelates of Gd.
Placental perfusion and permeability were measured in preg-
nant mice at late gestation in both physiological and pathological
settings. Placental perfusion was quantiﬁed using low-molecular-
weight, Gd-chelate contrast agents, which, after intravenous
administration to the mother, crossed the maternal-fetal barrier in
the placenta. The acquired data were analyzed using a three-
compartment, pharmacokinetic model [1,2]. This method has
been implemented in detecting and investigating abnormal
placental blood ﬂow due to noradrenaline administration [3], and
in rodent models of placental insufﬁciency [4,5]. Recently, the
steepest slope model, a robust numerical method providing
quantiﬁcation of perfusion from a minimal set of DCE-MRI images,
has been employed in a mouse model with the administration of
GdDTPA, a clinical MRI contrast media. This model enabled sepa-
ration of placental compartments, demonstrating high-ﬂow and
low-ﬂow compartments in all placentas, and allowed quantiﬁca-
tion of mean perfusion values in each compartment separately
(Fig. 1A) [6,7]. Placental perfusion has also been assessed using
superparamagnetic iron oxide (SPIO) nanoparticles, and applied in
a rat uterine artery ligation model of IUGR [8]. A signiﬁcant
advantage of this approach is that while Gd-based contrast agents
are not recommended for use during human pregnancy, SPIOs are
considered safe for clinical use. Thus, SPIO-based methods might
become a tool for studying IUGR in humans.
The maternal circulation within the placenta has been previ-
ously investigated by us, at different developmental stages, using a
macromolecular contrast agent, in which chelated Gd was cova-
lently linked to albumin [9]. Since maternal albumin does not cross
the fetal-maternal placenta barrier, the analysis of maternal circu-
lationwithin the placenta is not confounded by transfer to the fetal
circulation, as it can be with conventional Gd chelates. Using this
methodology, it was possible to differentiate normal placentas from
placentas undergoing resorption, and to resolve strain-speciﬁc
differences [9]. Additionally, the effect of Akt1, a major mediator
of angiogenesis, on placental vascular function was investigated
[10].
DCE-MRI has been applied to assess perfusion in primate
placenta, using manganese chloride [11], and standard Gd-based
chelates [12,13]. Frias et al., was able to construct three-
dimensional (3D) maps of placental structure, identifying
placental vascular domains, consistent with placental histopathol-
ogy. Furthermore, volumetric ﬂow estimated in each perfusion
domain closely matched the blood ﬂow through the uterine artery,
as measured by Doppler ultrasound [13].
The routine use of Gd chelates during human pregnancy is
considered controversial, due to possible risks to fetal develop-
ment. Conventional Gd agents have been administered intrave-
nously during human pregnancy in rare cases involving women
with a speciﬁc medical indication for DCE-MRI, typically the
investigation of conditions that are considered potentially life
threatening to the mother [14e16]. In a study undertaken a few
hours prior to delivery by caesarean section, Brunelli, et al., used
administration of gadoterate melamine to demonstrate that
perfusion was homogeneous in normal placenta, whereas in
pregnancies with severe IUGR, placental circulation was severelycompromised, displaying a slow intervillous blood ﬂow, and many
patchy non-perfused areas (Fig. 1B) [17].
These studies suggest that while DCE-MRI cannot be indicated
for routine clinical prenatal follow-up of normal pregnancy, it is a
robust method for measuring placental perfusion, and, thus, may
offer valuable information for basic understanding of the etiology
of placental diseases that may be translatable to humans.
3. Perfusion and ﬂow measurements using endogenous MRI
contrast
Translation of methods for measuring placental function from
pre-clinical to clinical settings would be aided greatly by imaging
protocols that do not require administration of an exogenous
contrast agent. By magnetically tagging blood in the feeding artery
(intrinsic contrast) and measuring its concentration in perfused
tissue a short time later, Arterial Spin Labeling (ASL) methodology
enables quantiﬁcation of tissue perfusion. A time scale of seconds,
characteristic of perfusion and nutrient exchange rates into the
placenta, is accessible by ASL. With appropriate kinetic modeling,
ASL allows quantitative assessment of important physiological
vascular parameters, including perfusion, and blood ﬂow.
Based on a modiﬁcation of the ASL method, we reported a novel
MRI tool, termed Bi-Directional ASL (BD-ASL), which enabled non-
invasive determination of fetal order along the uterine horn inmice
from the pattern of uterine versus ovarianmaternal blood ﬂow [18].
Together with ﬂuorescence imaging methods, these experiments
provided new insights into the structure and function of the com-
plex architecture of the uterine maternal vasculature in multi-fetal
pregnancies. Placental perfusion patterns suggest a collateral
perfusion of the placenta, with separate arterial input from each of
the feeding arteries, namely the uterine artery and uterine branch
of ovarian artery (Fig. 2A). In addition, BD-ASL was utilized to un-
derstand the genetic and environmental factors that affect
placental function, demonstrating the hemodynamic inﬂuence of
individual fetuses on their nearest neighbors [19].
Flow-sensitive alternating inversion recovery (FAIR), a deriva-
tive of the ASL technique, has been implemented in several in-
vestigations of human placenta. In normal pregnancies, a mean
placental perfusion rate of 176 ml/100 mg/min [20] was measured.
Francis et al., applied FAIR ASL to compare the pattern of perfusion
in normal versus IUGR-compromised pregnancies. Using perfusion
maps that allow visual and statistical comparison of the fraction of
perfusion, it was shown that the proportion of placentas with low
perfusion rates was higher in the IUGR group than in the normal
group (Fig. 2B) [21]. Reduced placental perfusion was also reported
during the second trimester of pregnancy in the basal plate area in
pregnancies complicated by small-for-gestational-age (SGA) fe-
tuses. The ﬁndings were strongly associated with the perfusion
values measured by diffusion MRI, and with impedance to ﬂow in
the uterine arteries, measured by Doppler ultrasound [22]. Duncan
et al., found no differences in placental perfusion between normal
and compromised pregnancies, although this study used a small
sample size and low-ﬁeld (0.5 T) MRI scanner, producing images
with lower signal to noise [23].
4. Oxygenation studies
Due to the paramagnetic properties of deoxyhemoglobin, the
oxygen state of the blood provides an endogenous MRI contrast
mechanism. Compartmentalization of deoxygenated hemoglobin
molecules creates magnetic susceptibility differences between red
blood cells and blood plasma, which increases R2* relaxation rates.
During a respiration challenge, changes in T2*-weighted BOLD signal
intensity are affected mainly by changes in the saturation of
Fig. 1. Perfusion measurements using contrast agents. (A) Mouse placental perfusion maps calculated by the steepest slope model on embryonic day (E) 14.5 (a,b) and E16.5 (c,d),
demonstrate, in all placentas, a high-ﬂow compartment (red colored), which lies within the central labyrinth zone, and a low-ﬂow compartment, which matches the peripheral
labyrinth and the junctional zone. Reprinted from Ref. [6], with permission from Elsevier. (B) Human placental circulation in normal and IUGR pregnancies. 3D Contrast-enhanced,
T1-weighted images acquired 2 min following administration of gadoterate meglumine in normal (c) and IUGR placentas (f). Normal placentas show a homogeneous signal increase,
while IUGR-complicated placentas display many patchy, non-perfused areas. Reprinted from Ref. [17], with permission from Elsevier.
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changes in tissue oxygenation.
BOLD MRI has been applied in animal models under different
maternal respiration challenges, with changes in the feto-placental
BOLD signal intensity measured in response to the challenge. A
hypercapnic respiration challenge in a maternal model of chronic
fetal asphyxia resulted in a marked, generalized attenuation of the
response in the placenta and fetal liver [24]. Recently, BOLD MRI
was utilized in a rat uterine artery ligation model for IUGR duringmaternal hyperoxygenation, demonstrating reduced response of
compromised placentas compared with controls (Fig. 3A), and
suggesting that this tool may be used to depict abnormalities in
oxygenation related to impaired placental perfusion and IUGR
[25,26]. Studies in sheep fetuses have shown that changes in
cotyledon and fetal BOLDMRI signals are closely related to changes
in fetal oxygenation estimated by fetal arterial hemoglobin satu-
ration [27], and by ﬂuorescent oxygen sensors inserted into the
fetal liver [28].
Fig. 2. Perfusion and ﬂow measurements using endogenous MRI contrast. (A) Assessment of the arterial blood supply to mouse placenta of an ICR pregnant mouse (E17.5) via
bidirectional arterial spin labeling (BD-ASL) MRI. AeC: Color-coded BD-ASL maps (red and blue, positive and negative BD-ASL values, respectively) show that placentas near the
cervix (Panel A: L1, R1) have negative BD-ASL values, whereas those near the ovary (Panel C: L5-7) have positive values. Placentas located in the middle of the uterine horn (Panel B,
L3-4) have a dispersive pattern of positive and negative BD-ASL values, suggesting a dual blood supply with separate arterial inputs from each of the feeding arteries [19]. (B) Left
panel: Placental perfusion maps overlaid on an MRI image for: (top) a normal pregnancy and (bottom) a pregnancy complicated by IUGR. The placental perfusion rate in pregnancy
complicated by IUGR is reduced, with many areas displaying infarction. Right panel: Histograms of placental perfusion fraction show a signiﬁcant difference between IUGR and
normal pregnancies in the distribution of perfusion categories. Reprinted from Ref. [21], with permission from Elsevier.
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oxygen levels have been demonstrated in human placenta and in a
number of fetal organs duringmaternal oxygen challenge. Maternal
hyperoxia was shown to increase placental oxygenation in healthy
pregnancies, as measured by an increase in BOLD signal intensities
(Fig. 3B) [29,30].
Oxygen-Enhanced (OE) MRI, which measures changes in T1
during a respiration challenge, is affected mainly by molecular
oxygen, which shortens tissue T1 via dipolar interactions. There-
fore, oxygen-induced changes in T1 reﬂect mainly the amount of
dissolved oxygen in plasma and tissue ﬂuid (i.e., PO2), the partial
pressure of oxygen. In combination with BOLD MRI, OE MRI was
applied to investigate the placental oxygen environment over a
range of gestations [31].
These preliminary clinical studies suggest that non-invasiveMRI
techniques are capable of measuring changes in placental and fetaloxygenation under maternal respiration challenge, providing new
possibilities for observing placental and fetal oxygenation status.
5. Microstructure
Diffusion weighted (DW) MRI is a sensitive approach for map-
ping the incoherent motions of water molecules, thereby providing
insight into tissue microstructure at the micrometer level. DWI
experiments typically report measurement of so-called apparent
diffusion coefﬁcients (ADCs).
Placental circulation can be roughly described as being
composed of a maternal vascular system lined with trophoblast
cells and a fetal system involving small blood capillaries. DW MRI
studies are unable to resolve these structures due to the small sizes
of cells and blood vessels. Moreover, placental mean ADC values
may reﬂect various types of movements beyond free water
Fig. 3. Oxygenation studies: (A) Effect of maternal hyperoxygenation on the placenta and different fetal organs in a rat ligation model of IUGR. Box-and-whisker plots summarize
changes in T2* values between hyperoxygenation and ambient air in placentas, fetal livers and fetal brains, in the normal and ligated IUGR uterine horns. There is a signiﬁcant effect
of maternal hyperoxygenation on BOLD SI in all organs. IUGR placentas show a signiﬁcant reduction in the BOLD response to hyperoxygenation. Reprinted from Ref. [26], with
permission from RSNA®; (B) Changes in human placental oxygenation BOLD signals during a maternal hyperoxic respiration challenge. Upper panel: Normalized BOLD SI of the
entire placenta, in three different slices, shows a signiﬁcant increase during maternal hyperoxia. Lower panel: Maternal and fetal areas within the placenta display different dy-
namics in response to maternal changes in oxygenation. Placental region of interests (ROIs) are shown in the inset images. Reprinted from Ref. [30], with permission from John
Wiley and Sons.
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strictions acting on the molecular diffusion, and exchange, and it is
impossible to distinguish between these motions using conven-
tional DW MRI experiments. We therefore recently combined DW
MRI with the emerging spatiotemporal encoding (SPEN) acquisi-
tion strategy, using a contrast-enhanced approach. By executing
ADC measurements in the presence and absence of albumin-based
contrast agent, b-BSAGdDTPA, and performing multi-exponential
analysis of placental signal intensity, we were able to resolve
multiple placental compartments and to characterize the move-
ment of water in each compartment based on derived ADC values.
Using this hybrid imaging strategy, we found that water motion in
the maternal compartment is driven mainly by free diffusion,
whereas water movement in the fetal compartment, which
exhibited two orders of magnitude higher ADC values than the
maternal ones, is dominated by ﬂow. Finally, the movement of
water in the trophoblast compartment, which displayed interme-
diate ADC values that were considerably higher than those ex-
pected for free diffusion, is dominated by contributions from ﬂuid
being actively ﬁltered across the fetalematernal barrier, and not by
stationary intracellular water (Fig. 4A) [32].
Intravoxel incoherent motion (IVIM) is a derivative of DW MRI
that attempts to distinguish between diffusion and perfusion of
ﬂuids. IVIM is appropriate for highly vascularized organs containing
high blood fraction and a large, anisotropic perfusion component,
like the placenta, and has been implemented in a rat uterine artery
ligation model for IUGR to assess placental perfusion. Using this
approach, it was possible to detect a reduced perfusion fraction in
compromised placentas, relative to normal ones [33].
DW MRI has been widely applied over the last few years to
assess human placental structures under normal conditions
[34,35], and in high-risk pregnancies [22,36e42]. Using the IVIMmethod, Moore, et al., identiﬁed differences between placentas of
IUGR-complicated pregnancies and normal pregnancies. In normal
pregnancies, different zones of blood movement were visible
within the placentas, whereas in IUGR-complicated pregnancies,
the placentas appeared far more homogenous, with their outer
zones containing a signiﬁcantly reduced proportion of moving
blood compared to the normal cases (Fig. 4B) [36,37]. Other DW
MRI studies in placentas complicated by IUGR have shown an
overall reduction in placental diffusion [38], perfusion [22,39], and
functional placental blood volume [39]. IVIM was also imple-
mented in pregnancies complicated by PE, detecting a reduced
fraction of mobile blood in the basal plate area of the placentas [40].
Sohlberg et al., found a clear difference between early onset (<34
weeks) and late onset (>34 week) PE, demonstrating a smaller
perfusion fraction in early onset, but large perfusion in late onset,
compared with normal [41]. Lastly, DW MRI has been shown to
detect and deﬁne placental invasion in pregnancies complicated by
placenta increta [42].
6. Metabolism
Magnetic Resonance Spectroscopy (MRS/NMR Spectroscopy) is
a non-invasive method for determining the chemical structure of
molecules, providing information about speciﬁc metabolites con-
tained within selected regions of interest, which can be translated
for assessment of the metabolic proﬁle of tissues in vivo. NMR
spectra can be used to detect speciﬁc metabolites; the area under
each spectral peak is proportional to the concentration of the
metabolite. The most common nuclei studied by MRS are hydrogen
(1H) and phosphorus (31P).
As a result of numerous limitations imposed by the in vivo
setting, most placental studies have utilizedMRS techniques in vitro
Fig. 4. Microstructure: (A) Resolving mouse placental structures using a hybrid strategy, combining DW MRI, contrast-enhanced under SPEN acquisition. Upper panel: Estimated
placental compartmental fraction. Lower panel: Corresponding ADC values in each compartment. According to this analysis, maternal, fetal, and trophoblastic contributions
constitute 66%, 24%, and 10% of overall placental volume, respectively. ADC values reveal a freely diffusive maternal blood pool, a strongly perfused fetal blood ﬂow, and inter-
mediate behavior for the trophoblastic labyrinth cell layer [32]. (B) Human placental perfusion fraction maps in normal and IUGR pregnancies, measured using IVIM. Perfusion
fraction maps overlaid on MRI images for normal pregnancy (upper panel), indicating two zones of blood movement, and for pregnancy complicated by IUGR (lower panel), in
which the placenta appears far more homogenous, with its outer zone containing a signiﬁcantly reduced proportion of mobile blood. Reprinted from Ref. [37], with permission from
Elsevier.
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placentas and the corresponding low sensitivities for detection of
metabolites, no studies have been performed in animal models.
Clinical studies are currently restricted due to the sensitivity of the
imaging coil, and thus are limited to women with anterior pla-
centas and low body fat.
Phospholipid metabolism has been studied in normal human
placenta by in vivo 31P MRS [43]. Recently, placental membrane
metabolism has been investigated using 31P MRS in women with
normal pregnancies and those with early (<34 weeks) and late
(>34 weeks) onset PE. Phosphodiester (PDE) spectral intensity and
the PDE-to-phosphomonoester spectral intensity ratio (PDE/PME)
are factors associated with cell-membrane degradation and for-
mation. It was shown that both PDE intensity and the PDE/PME
ratio increased with increasing gestational age in normal preg-
nancy, and these increases were larger in early onset PE than in late
normal pregnancy (Fig. 5A). These results indicate that with
increasing gestational age in normal pregnancy, and in early onset
PE, increased cell degradation and increased apoptosis may occur
[44].
1H MRS has been utilized to assess the metabolic proﬁle of
placental tissue in healthy and IUGR pregnancies. In healthy preg-
nancies, a signiﬁcant choline (Cho)/lipid ratio was detected,
whereas in IUGR-complicated pregnancies, Cho peak was severely
attenuated or absent from all placentas, indicative of a reduction in
cell turnover (Fig. 5B) [45]. A proof-of-concept study was per-
formed assessing placental glutamine and glutamate (Glx) to Cho
ratios (Glx/Cho) in healthy and IUGR pregnancies. The Glx/Cho ratiowas lower for IUGR placentas than in those of matched controls
[46]. These studies suggest that abnormal placental 1H MR spectra
can serve as an early biomarker of altered placental metabolism.
In vivo MRS techniques could be greatly improved with the use of
improved coil design to provide a more homogeneous transmitting
ﬁeld, which would provide better localization and allow compari-
son of slices recorded at different depths.7. Summary and future perspectives
Early identiﬁcation of high risk fetuses and timing of delivery are
among the main challenges in modern day obstetrics. Functional
MRI of the placenta can provide valuable information on several
important physiological parameters, including blood ﬂow, perfu-
sion and oxygenation status, which could potentially serve as
sensitive biomarkers for negative changes, even at early pregnancy
stages. However, despite the availability of numerous MRI tech-
niques for studying placental function, in vivo studies of the
placenta are limited, and, currently, there is no acceptedMRI-based
deﬁnition of normal or pathological placental function. This may be
due, in part, to several technical challenges, including the lack of
consensus on imaging protocols, poor image quality, especially in
low ﬁeld magnets, and the limited availability of MRI scanners,
relative to US, preventing the acquisition of data from a large
number of pregnancies. Additional obstacles arise from the com-
plex vascular architecture of the placenta, which often leads to
inconclusive data and inadequate theories for describing the signal
Fig. 5. Metabolism: (A) 31P MRS in healthy and IUGR complicated pregnancies: Upper panel: representative 31P spectrum of a normal human placenta at 38 weeks gestation (a),
ﬁtted spectrum (b), and residual (c). Spectral intensities of the following metabolites were evaluated: phosphomonoesters (PME ¼ phosphoethanolamine (PE) þ phosphocholine
(PC)); inorganic phosphate; phosphodiesters (PDE ¼ glycerophosphoethanolamine (GPE) þ glycerophosphocholine (GPC)); phosphocreatine (PCr); and adenosine triphosphate
(ATP). Lower panel: Scatter plot displaying PDE/PME spectral intensity ratio in early onset (<34 weeks) PE versus normal pregnancy. Women with early onset preeclampsia have a
higher PDE/PME spectral intensity ratio than women with normal pregnancies. Reprinted from Ref. [44], with permission from Elsevier. (B) 1H MRS: upper panel: placental 1H MRS
spectrum acquired from normal human pregnancy. Choline and lipid spectral peaks appear at frequencies of 3.21, 1.3 and 0.9 parts per million (ppm), respectively. Lower panel:
Placental 1H MRS spectrum acquired from IUGR-compromised pregnancy. The lipid spectral peak appears at a frequency of 1.42 ppm. The choline peak is below the level of reliable
detection. Reprinted from Ref. [45], with permission from PLOS ONE.
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parameters and physiological factors.
To advance the ﬁeld, there is a need for more basic research
studies using animal models to enhance the understanding of
pregnancy complications and to expand the development of
novel imaging tools for studying placental function. As inter-
pretation of MRI data can be very complex and is often ambig-
uous, there is a need for more robust computational methods
and for the standardization of information that can provide ab-
solute quantiﬁcation of placental functional metrics, indepen-
dent of magnetic-ﬁeld strength, image-sequence parameters,
and scientiﬁc center. Separating and distinguishing different
placental compartments could prevent bias from averaging their
different contributions. Moreover, the use of hybrid methods,
combining several MRI techniques, may provide new informa-
tion, allow comparison between different parameters, and
reduce the costs and number of patients/animals. Finally,
switching to higher ﬁeld strengths may offer some advantages,
including improved sensitivity and image quality, longer T1
relaxation time constants, which increases the time window
accessible for transfer of label before recovery of the signal, and
higher T2*-based contrast, as T2* effects are more pronounced in
higher ﬁeld strengths. However, artifacts worsen with increasing
magnetic strengths, and the speciﬁc absorption rates (SAR) are
increased, adding safety concerns. In clinical settings, magnetic-
ﬁeld strength of 3T may provide a good compromise between all
of these factors, whereas in small-animal models, higher ﬁeldstrength, such as 9.4T, should be used to enable high quality
images despite the small sizes of placental structures.
We hope that in the near future, many of these techniques will
be available for routine clinical practice to distinguish between
normal and compromised pregnancies. Methods that offer infor-
mation that is not available using US assessments, such as feto-
placental oxygenation status, or other methods that do not
require the use of exogenous contrast agents, would be of particular
value.
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